# A Study in Healthy Men to Test How BI 1569912 is Processed in the Body

> **NCT06520553** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1569912 (C-14)
- **DRUG:** BI 1569912 (C-13)

## Key facts

- **NCT ID:** NCT06520553
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-26
- **Primary completion:** 2024-10-03
- **Final completion:** 2024-10-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520553, "A Study in Healthy Men to Test How BI 1569912 is Processed in the Body". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06520553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*